About HS Code 2937
HS Code 2937 covers hormones, prostaglandins, thromboxanes, and leukotrienes, whether natural or reproduced by synthesis, along with their derivatives and structural analogues, including chain-modified polypeptides, used primarily as hormones. This heading is critical for the pharmaceutical and biotechnological industries, encompassing potent biological regulators essential for medicinal treatments, research, and veterinary applications. The scope is defined by the primary use as a hormone or related compound, irrespective of whether it's a naturally extracted substance or a synthetic analogue. This includes complex polypeptide hormones like insulin and growth hormone, as well as steroid hormones like testosterone and estrogen. The classification here is paramount for trade compliance due to the high potency, strict regulatory controls, and often high value of these substances. Their trade is heavily scrutinized by health authorities globally, requiring specific permits, adherence to Good Manufacturing Practices (GMP), and rigorous quality control. This heading falls under Chapter 29, emphasizing their identity as specific, complex organic chemical compounds rather than finished pharmaceutical products, although their ultimate destination is often for drug formulation. The advancement of biotechnology has significantly expanded the range of synthetic and recombinant hormones traded under this code.
Products Under This Code
Insulin (synthetic), Human Growth Hormone (Somatropin), Testosterone, Estradiol, Progesterone, Cortisone, Adrenaline (Epinephrine), Thyroxine, Oxytocin, Melatonin, Prostaglandin E2, Leuprolide, Desmopressin, Glucagon, Calcitonin, Prednisolone, Dexamethasone, Gonadorelin, Triptorelin, Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Atosiban, Somatostatin, Methandrostenolone
Real World Examples
A Danish pharmaceutical company exports bulk synthetic human insulin to a drug manufacturer in India via refrigerated air freight for the production of diabetes medication. A US biotechnology firm ships research-grade Prostaglandin F2 alpha to a university laboratory in Germany for reproductive physiology studies, using specialized cold chain courier services. A Chinese manufacturer supplies veterinary-grade progesterone to livestock breeders in Argentina for synchronized breeding programs, typically transported by ocean container with temperature controls. A Swiss specialty chemical company imports bulk Testosterone propionate from an Italian producer for further processing into hormone replacement therapies, often via secure air cargo.
Common Misclassification
Misclassification often arises when distinguishing between bulk hormones (2937) and prepared pharmaceutical dosage forms (Chapter 30). If hormones are compounded into tablets, injections, or other measured doses for therapeutic or prophylactic use, they are classified under Chapter 30 (e.g., 3004). Another common error is confusing hormones with enzymes (Chapter 35), which are also biological macromolecules but function as catalysts rather than signaling molecules. Additionally, some complex proteins that are not primarily hormones might be incorrectly placed here; Chapter 35 or other specific protein headings (e.g., 3824) might apply. The crucial factor for 2937 is the substance's primary function as a hormone or related compound.
Subheadings 9
Industry
This code belongs to the Chemicals industry.
Trade Overview
Leading exporters of hormones and related compounds include Denmark, the United States, Switzerland, and Germany, reflecting their advanced pharmaceutical and biotechnological industries. Major importers include the United States, European Union countries, Japan, and India, driven by their large healthcare sectors and drug manufacturing capabilities. Due to their potent nature and medical significance, these goods are subject to stringent international regulations, including import permits, export controls, and adherence to Good Manufacturing Practices (GMP). While tariffs may be low or zero under various trade agreements, non-tariff barriers related to health and safety standards are significant.
Frequently Asked Questions
What is HS code 2937?
HS code 2937 is a 4-digit heading in the Harmonized System that covers: Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones.. HS Code 2937 covers hormones, prostaglandins, thromboxanes, and leukotrienes, whether natural or reproduced by synthesis, along with their derivatives and structural analogues, including chain-modified polypeptides, used primarily as hormones. This heading is critical for the pharmaceutical and biotechnological industries, encompassing potent biological regulators essential for medicinal treatments, research, and veterinary applications. The scope is defined by the primary use as a hormone or related compound, irrespective of whether it's a naturally extracted substance or a synthetic analogue. This includes complex polypeptide hormones like insulin and growth hormone, as well as steroid hormones like testosterone and estrogen. The classification here is paramount for trade compliance due to the high potency, strict regulatory controls, and often high value of these substances. Their trade is heavily scrutinized by health authorities globally, requiring specific permits, adherence to Good Manufacturing Practices (GMP), and rigorous quality control. This heading falls under Chapter 29, emphasizing their identity as specific, complex organic chemical compounds rather than finished pharmaceutical products, although their ultimate destination is often for drug formulation. The advancement of biotechnology has significantly expanded the range of synthetic and recombinant hormones traded under this code.
What products fall under HS code 2937?
Insulin (synthetic), Human Growth Hormone (Somatropin), Testosterone, Estradiol, Progesterone, Cortisone, Adrenaline (Epinephrine), Thyroxine, Oxytocin, Melatonin, Prostaglandin E2, Leuprolide, Desmopressin, Glucagon, Calcitonin, Prednisolone, Dexamethasone, Gonadorelin, Triptorelin, Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Atosiban, Somatostatin, Methandrostenolone
What are common misclassifications for HS code 2937?
Misclassification often arises when distinguishing between bulk hormones (2937) and prepared pharmaceutical dosage forms (Chapter 30). If hormones are compounded into tablets, injections, or other measured doses for therapeutic or prophylactic use, they are classified under Chapter 30 (e.g., 3004). Another common error is confusing hormones with enzymes (Chapter 35), which are also biological macromolecules but function as catalysts rather than signaling molecules. Additionally, some complex proteins that are not primarily hormones might be incorrectly placed here; Chapter 35 or other specific protein headings (e.g., 3824) might apply. The crucial factor for 2937 is the substance's primary function as a hormone or related compound.
Which countries trade the most under HS code 2937?
Leading exporters of hormones and related compounds include Denmark, the United States, Switzerland, and Germany, reflecting their advanced pharmaceutical and biotechnological industries. Major importers include the United States, European Union countries, Japan, and India, driven by their large healthcare sectors and drug manufacturing capabilities. Due to their potent nature and medical significance, these goods are subject to stringent international regulations, including import permits, export controls, and adherence to Good Manufacturing Practices (GMP). While tariffs may be low or zero under various trade agreements, non-tariff barriers related to health and safety standards are significant.
How is HS code 2937 structured?
HS code 2937 is a 4-digit heading under Chapter 29 of the Harmonized System. The first 2 digits (29) identify the chapter, and digits 3-4 (37) specify the heading. This code contains multiple 6-digit subheadings for precise product classification.